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Key questions
What is already known?
 ► In low-income and middle-income countries (LMICs), 
where access to health services is problematic and 
the health system is weak, a nationwide campaign 
outreach approach is a predominant child health 
service delivery strategy to reach as many children 
as possible in a relatively short period of time.
 ► There has been a dramatic increase in the number 
of key child health and nutrition interventions deliv-
ered through integrated child health events (ICHEs), 
where up to 96 events in 2010 from 2 events in 
1999, with 73 countries having carried out these 
campaigns by 2010.
What are the new findings?
 ► The study demonstrated that ICHEs are a frequently 
used platform, often delivering multiple interventions 
without compromising coverage outcomes of some 
key interventions delivered through the campaigns.
 ► This study provides a comprehensive analysis of 
ICHEs exploring at a much wider range of child 
health campaign models implemented globally by 
combining both Child Health Days and immunisa-
tion-focused campaigns.
What do the new findings imply?
 ► This study illustrates the continued prominence of 
campaign-mode of health service delivery (specifi-
cally ICHEs), suggesting that their role as a means 
of delivering multiple child health services in LMICs 
should be re-thought in line with health system 
strengthening.
 ► This study may open up choices for policymakers 
and project managers to potentially add-on more 
interventions when delivering child health and nu-
trition services through campaigns. However, sys-
tematic collection and analysis of operational data 
related to ICHE are critical to better understand the 
determinants of their effectiveness.
AbsTrACT
Introduction Delivering child health services through 
integrated child health events (ICHEs) has been a useful 
and popular strategy implemented in many in low-income 
and middle-income countries (LMICs) to accelerate the 
reduction of child mortality. The study aims to portray the 
scope of ICHEs and examine the association between the 
number of child health-nutrition interventions and types 
of ICHE packages delivered through these campaigns with 
vitamin A supplementation (VAS) and measles vaccination.
Methods Secondary data analysis was conducted using 
Unicef global campaign database (1999–2010), where 
597 ICHEs from 76 countries were analysed. Panel 
random effects regression models were used to explore 
the association between the number of interventions 
and coverage for VAS and measles vaccination, and non-
parametric Kruskal-Wallis test to explore the association 
between different intervention packages and VAS coverage.
results An average of 100 ICHEs were conducted per 
year between 2005 and 2010, highest in sub-Saharan 
Africa (60%). By 2010, 40 ICHEs out of 66 (60%) across 
24 countries delivered 5 or more interventions during 1 
ICHE. No statistically significant effect of the number of 
ICHE interventions on VAS coverage was found (−0·76, 
p=0·185). There was a small significant effect on measles 
coverage (−1·81, p=0·057), which was not robust to 
model specifications removing outlier observations with 
measles coverage lower than 40%. The Kruskal-Wallis 
test did not suggest a significant association between 
different intervention packages and VAS coverage at 5% 
significance level (p=0·07).
Conclusion ICHEs were found to be a widely used 
strategy to deliver essential child health-nutrition 
interventions in LMICs. ICHEs appear to represent a 
commonly used platform with the capacity to incorporate 
multiple interventions without compromising coverage of 
some key interventions as VAS and measles vaccination. 
More research is required to better understand what 
operational factors may affect the coverage outcomes 
delivered together through ICHEs.
InTroduCTIon
Expanding access to cost-effective child 
health services through integrated child 
health events (ICHEs) has been recognised 
as a viable strategy and implemented in many 
settings to accelerate the reduction of child 
mortality in low-income and middle-income 
countries (LMICs). Pursuing multiple delivery 
of interventions through ICH campaigns is 
considered an important driver to accelerate 
progress to reduce child mortality towards 
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Table 1 Different manifestations of integrated child health 
events
Name Countries
Child Health Days
Child Days Plus Uganda
Child Health Days Botswana, Ghana, Guinea-Bissau, 
Liberia, Mali, Mauritania, Senegal, 
Sierra Leone, Somalia, Swaziland and 
Togo
Child Health Week Mozambique and Zambia
Child Survival 
Campaign
Central Africa Republic, Chad, the 
Democratic Republic of the Congo, 
Guinea and Senegal
Enhanced Outreach 
Strategy
Ethiopia
Maternal and Child 
Health Week
Sierra Leone
Maternal and 
Neonatal Child 
Health Week
Nigeria
Mother and Child 
(Health) Week
Burundi, Madagascar, Pakistan and 
Rwanda
National Child Health 
and Nutrition Week
Eritrea
National Health Days Angola
National 
Micronutrient Days
Burkina Faso and Niger
National Vitamin A 
Supplementation 
and Deworming 
Days
Congo, the Democratic Republic of 
the Congo, India, Myanmar, Nepal 
and Togo
Sustained Outreach 
Services
Indonesia
Disease-prevention priority campaigns
Immunisation week/
campaigns
Afghanistan and Papua New Guinea
Measles/polio 
supplementary 
immunisation 
activities
Over 28 countries in LMICs (2014), 
such as Afghanistan, the Democratic 
Republic of the Congo, Haiti, Kenya, 
the Republic of the Congo, Zambia, 
etc
National 
immunisation days
Angola, Benin, Burkina Faso, 
Cameroon, Central African Republic, 
Chad, Cote d’Ivoire, the Democratic 
Republic of the Congo, Equatorial 
Guinea, Gabon, Gambia, Ghana, 
Guinea Bissau, Mauritania, Niger, 
Nigeria, the Republic of the Congo 
and Senegal
LMICs, low-income and middle-income countries.
the Sustainable Development Goals. This has occurred 
in parallel to other mainstream models of delivery of key 
child health interventions where access to health services 
is problematic and the health system is weak, particularly 
in many countries in sub-Saharan Africa. A nationwide 
campaign approach has been used in over 73 countries, 
with 154 events conducted in 2010 alone, with an average 
of 100 campaigns conducted globally per year.1 However, 
the relationship between the number of interventions 
delivered or with the different packages of interventions 
and coverage outcomes of specific interventions, such as 
vitamin A supplementation (VAS) and measles, has been 
underexplored.
ICHEs—a terminology developed for this study—can 
be broadly defined as any campaign-style events that 
deliver two or more maternal and child health and nutri-
tion services at any given time during any given year. 
These campaigns are manifested in various forms and 
are referred to as by different names (table 1). This new 
terminology encompasses the wide variety of campaigns 
revealed in various forms. Creating the ICHE termi-
nology enabled the exploration of these interventions 
from a broader perspective rather than examining Child 
Health Days (CHDs) or immunisation campaigns sepa-
rately, as there are many commonalities and overlaps 
as well as differences between these. Having a common 
terminology for these integrated campaigns enabled a 
comprehensive analysis and provided an overall picture 
of how these types of events function.
This analysis focused on the combinations of two main 
types of ICHEs: (1) CHDs and (2) immunisation-focused 
campaigns. The main difference between ICHEs and 
CHDs is that ICHE is an overarching terminology that 
includes CHD and immunisation-focused campaigns. 
CHDs are conducted twice a year, usually 6 months apart 
and always include VAS. The two immunisation-focused 
campaigns analysed are measles supplementary immuni-
sation activities (SIAs) and polio national immunisation 
days (NIDs) (box 1 for the definition of key terminolo-
gies). Other types of disease prevention campaigns were 
not fully captured in the data set used in this study.
Many LMICs have been able to provide additional 
health service packages using the campaign-style delivery 
approaches to take advantage of available resources 
and ‘piggy-back’ on existing delivery mechanisms.2 3 A 
growing body of evidence has suggested that the delivery 
of child health and nutrition interventions through 
immunisation delivery channels has helped to achieve 
rapid, high and equitable coverage4 5 at low cost.6–8 
There are also indications that integrated delivery, such 
as CHDs and SIAs, contribute to improved immunisa-
tion coverage.9 10 Other studies showed SIAs improving 
access and efficiency11 and reducing disease outbreaks,12 
and CHDs greatly enhancing VAS and other intervention 
coverage outcomes.13 14 Even where routine immunisa-
tion is strong, immunisation contacts were found to serve 
as excellent vehicles for delivering additional interven-
tions.15 16
Countries are increasingly adding to the package of 
interventions delivered throughout these campaigns,17 
though the magnitude and scope of the existence and 
utilisation of ICHEs to deliver multiple child health inter-
ventions in LMICs has yet to be portrayed. Drawing on 
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the literature based on existing studies, many of which 
analyse vertical modes of delivery,18 19 the hypothesis is 
that increasing the number of interventions delivered 
through ICHE may negatively affect the coverage of these 
interventions. It can be presumed that the increased 
volume of services delivered at one time could lead to 
higher financial and human resource burden on districts 
and health workers; therefore, affecting performance 
and coverage of the interventions.
This study aimed to explore the scope and magnitude 
of the application of ICHEs in delivering multiple child 
health interventions in LMICs, to examine the associa-
tion between the number of interventions delivered 
through ICHEs and VAS and measles coverage outcomes, 
and to analyse the association between VAS coverages and 
the different intervention packages delivered through 
ICHEs.
This study advances the knowledge beyond the only 
other analysis by Palmer et al20—which draws on the 
same Unicef CHD database but focuses on CHDs only—
taking a new angle by considering multiple types of 
campaigns, including CHDs, SIAs and NIDs. It calculates 
the number of interventions delivered through these 
campaigns and analyses the association with coverage 
outcomes. This study complements Wallace, Ryman and 
Dietz’s systematic reviews on integrated immunisation 
campaigns (2009, 2012), which looked at the delivery of 
additional maternal–child health services using immuni-
sation programmes and the compatibility of integrating 
services. They found that when additional services are 
carefully selected for compatibility and the integrated 
delivery operations receive adequate support, coverage 
of these interventions may improve, provided that immu-
nisation coverage is already high. This study goes further 
by statistically exploring the potential effects of deliv-
ering multiple interventions during these integrated 
campaigns, and provides a comprehensive scope to the 
extent that integrated campaigns are used to deliver 
multiple health and nutrition services in LMICs.
MeTHods
data description
The original global Unicef CHD database was obtained 
with permission from Unicef Health and Nutrition 
sections at New York headquarters in 2010, and an 
updated version from 2013 was used in this analysis. The 
CHD database (box 2) contains information of integrated 
events from 83 countries from 1999 to 2010. In the CHD 
database, VAS estimates were taken from administrative 
campaign coverage results, and measles SIA coverage 
was obtained from WHO/Unicef joint reporting form 
(JRF) immunisation database, which is also derived from 
administrative results in addition to surveys reported 
annually by each country. Due to the different structure 
in the VAS database and JRF records, coverage records 
were matched by the month that campaigns occurred. It 
is important to note that the Unicef’s VAS and the WHO/
Unicef JRF immunisation database, from which the CHD 
database was created, represented the most complete 
source of information available on VAS and immunisa-
tion campaign coverage at the time of the study. Unicef 
CHD database was also the only database available that 
has assembled information on multiple child health 
campaigns on a global scale.
The ICHE database used for the analysis is a revised 
version of the original Unicef CHD database, modified by 
the authors for this analysis. The different vaccines deliv-
ered were recounted as separate interventions instead 
of grouping them together under ‘immunisation’ as 
was the case in the original CHD database, resulting in 
a more accurate number of interventions for each event. 
As complete information on event composition was avail-
able only from 2005 to 2010, data from 1999 to 2004 were 
excluded from this analysis. This totalled to 597 ICHEs 
that were held within 2005–2010, in a total of 73 coun-
tries. The revised database is referred to as the ICHE 
database in this paper.
Out of 597 events included in the ICHE database, 97% 
(577 events) had VAS coverage data, and 24% (142 cases 
in 50 countries) also indicated measles as a co-delivered 
intervention, among which 55% had measles coverage 
information. Additional measles coverage data points 
were not permitted by Unicef to be incorporated into the 
data set, though additional measles SIA events may have 
occurred, due to the close vigilance of measles coverage 
indicators by Unicef and WHO. Therefore, for this anal-
ysis, 577 events were used to analyse the correlations for 
VAS and 78 events for measles.
data analysis
Descriptive statistics were used to measure types of inter-
vention delivered, number of interventions co-delivered 
during ICHEs and different package of interventions. 
Under coverage outcomes, the relationship between 
VAS and measles coverage with the different numbers 
of interventions was explored through panel regression. 
Given that in each country vaccination campaigns can 
occur twice a year, ‘semester’ was used as a time variable 
rather than ‘year’. A random effects regression model 
with country and time effects was specified for country i 
at semester t (model 1):
Intervention coverageit=Number of interventionsit+Semestert+εit
where εit=fi+ut+eit
The composite error term εit comprises country-specific 
effects (fi), time effects (ut) and idiosyncratic error (eit). The 
Hausman test was used to determine whether a fixed-effect 
or random-effect was more appropriate. The test could 
not reject the hypothesis of correlation between indi-
vidual errors and the regressor neither for VAS coverage 
(p=0·661) nor for measles coverage (p=0·765), hence a 
random effects model was used as a base specification 
in both cases. On the basis of the existing literature, we 
expected that coverage for VAS and measles interventions 
would decrease with the number of interventions, hence a 
negative coefficient for ‘Number of interventions’.
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Figure 1 Number of ICHEs by year, globally (2005–2010). 
ICHEs, integrated child health events.
A range of robustness checks was conducted. Eight 
alternative regression specifications were tested, some of 
them with additional explanatory variables accounting 
for domestic and external health system spending, size of 
the under-5 population and density of human resources 
for health, in addition to sensitivity analyses with outliers 
removed. First, the following regression specifications 
were tested as alternatives to the base model (model 1): 
pooled ordinary least squares (OLS) regression (naive 
OLS ignoring the panel structure of the data set) (model 
2); panel regression with country fixed effects and no 
time effects (model 3); panel regression with country 
fixed effects and time effects (model 4); model 4 with 
additional predictors—total population aged 0–4 years, 
log government health expenditure per capita (IntUS$), 
log external health expenditure per capita (IntUS$) and 
average density of nurses and midwives (per 10 000 popu-
lation) in the interval 2004–2010 (model 5); panel regres-
sion with country random effects and no time effects 
(model 6); the base model with additional predictors, as 
per model 4 (model 7); panel regression using the with-
in-between estimator21 (model 8) and model 8 with addi-
tional predictors (model 9). The technical details are in 
appendix 1. Second, a sensitivity analysis with multiple 
cut-offs was performed with a restricted sample of obser-
vations, where outliers with intervention coverage of less 
than 40%, 60% and 80% were eliminated.
The number of interventions per event was categorised 
as either low (two to four interventions) or high (at least 
five interventions); the cut-off was informed empirically by 
an examination of the distribution of number of interven-
tions per event, exhibiting a right skew commencing at five 
interventions per event. Analyses were conducted using 
Excel V.2010, Stata V.10 and R V.3·3·2 statistical packages.
Patient and public involvement
Patients were not involved in this study.
resulTs
distribution and frequencies of ICHes
The highest numbers of ICHEs occurred in sub-Saharan 
Africa (62%), and then followed by East and Southern 
Asia and Pacific (26%). The number of ICHEs conducted 
each year among observations since 2005, where data was 
available, has been relatively stable, averaging approxi-
mately 100 events globally per year in the period 2005–
2010 (figure 1). This demonstrates a significant reliance 
on delivering multiple interventions through ICHEs in 
LMICs.
Types and packages of intervention delivered
Among the 597 ICHEs, the most common interventions 
delivered were VAS (99%), deworming (70%) and oral 
polio vaccine (OPV) (46%) (box 3). In terms of the 
combinations of antigens delivered together, out of the 
597 events, 78 co-delivered OPV and measles; 55 co-deliv-
ered OPV and tetanus toxoid (TT); 35 delivered measles 
and TT; and 30 co-delivered OPV, measles and TT. Due 
to the differing skills, resources and time required to 
deliver the different types of vaccines, it was important 
to consider each vaccine delivered as separate interven-
tions.
number of interventions co-delivered during ICHes
Overall, the range of the number of child survival inter-
ventions delivered through a single ICHE was between 
2 and 11. The proportion of countries delivering a high 
number of interventions increased year by year (appendix 
2), with 82% of the total events delivering three or more 
interventions by 2007. In 2010, 40 events out of 66 (60%) 
across 24 countries delivered five or more interventions 
during one campaign (box 4), and where five countries 
delivered as much as 10–11 simultaneous interventions, 
exemplifying the shift to delivering a high volume of 
interventions through these campaigns. The increasing 
shift towards co-delivered services was particularly marked 
in West and Central Africa, in addition to Eastern and 
Southern Africa. The proportion of ICHEs including five 
or more interventions was predominantly in sub-Saharan 
Africa, representing 71% of all events (box 5).
Countries which delivered five or more interventions 
between 2005 and 2010 are listed in table 2. The largest 
number of interventions during ICHE were in Nigeria 
and the Philippines, where 11 interventions were deliv-
ered in 2010, followed by 10 interventions in the same 
countries along with Zambia. Nicaragua, Somalia, South 
Sudan, Nigeria, Madagascar, Ghana and Uganda have 
delivered nine interventions at once in varying years, all 
delivering a variety of packages of maternal and child 
health interventions.
The question of whether the same countries tend to 
deliver five or more interventions at one event was also 
explored. Zambia ranked the highest in this respect (12 
occurrences), with a delivery of five or more interventions 
in 2005–2010 (box 6). In Zambia’s case, between five and 
seven interventions were delivered between 2005 and 
2009, and the number of interventions increased later on 
(in 2010 and 2012), especially with the adoption of the 
SIA strategy to achieve nationwide measles coverage (veri-
fied with project managers, Zambia, May 2014). Other 
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Table 2 Countries which delivered five or more 
interventions during ICHEs (2005–2010)
Country Year
No. of 
interventions
Nigeria and the Philippines 2010 11
Nigeria, the Philippines and Zambia (×2) 2010 10
Nicaragua and South Sudan 2010 9
Nicaragua, Nigeria and Somalia (×2) 2009 9
Madagascar 2008 9
Ghana and Uganda 2006 9
Burundi (×2), Mozambique (×2), Rwanda 
(×2), Sudan and Uganda (×2)
2010 8
Sierra Leone 2009 8
Madagascar, Nigeria and Rwanda 2008 8
Cameroon (×2), DR Congo, Sierra Leone 
(×2) and Vietnam (×2)
2010 7
Angola, Burkina Faso (×2), Ethiopia, 
Sierra Leone, South Sudan, Togo, 
Uganda (×2) and Zimbabwe
2009 7
The Philippines, Sierra Leone, Sudan 
and Zambia
2008 7
Indonesia, Nigeria and Zambia 2007 7
Uganda 2006 7
Cambodia 2005 7
Haiti, India (×2), Lao PDR (×2), 
Madagascar and Somalia (×2)
2010 6
Burundi, Central African Republic, 
Eritrea, Ethiopia, Nigeria, Swaziland, 
Vietnam (×2) and Zambia (×2)
2009 6
Djibouti, Ghana, Kenya (×2), 
Mozambique, Nigeria, the Philippines 
and Zambia
2008 6
Central African Republic (×2), Djibouti, 
Ghana, Indonesia, Malawi, Nigeria, the 
Philippines (×2) and Timor Leste (×2)
2007 6
Ethiopia (×2), Ghana, Indonesia, 
Madagascar, Nicaragua and Zambia (×2)
2006 6
Zambia (×2) 2005 6
Burkina Faso (×2), Cote d’Ivoire, 
Ethiopia, Liberia, Madagascar, Niger and 
Senegal
2010 5
Burundi, Chad (×2), Ecuador, Guinea, 
Lao DPR, Korea DPR (×2), Rwanda (×2), 
Senegal and Zimbabwe
2009 5
Burkina Faso (×2), DR Congo, Ghana, 
India (×2), Korea DPR, Togo, Tanzania, 
Uganda (×2) and South Africa
2008 5
Eritrea (×2), Ethiopia (×2), Gabon, 
Cambodia, Marshall Island (×2), Mali, 
Nicaragua, Korea DPR, Swaziland, 
Uganda, Zambia and Zimbabwe
2007 5
Angola, Belize (×2), Kenya, Maldives (×2) 
and Sierra Leone
2006 5
Burundi, Ethiopia (×2), Ghana, Maldives 
(×2), the Philippines (×2), Senegal and 
Uganda
2005 5
DPR, Democratic People's Republic; DR, Democratic Republic; 
ICHEs, integrated child health events; PDR, People's DR.
countries, such as Uganda, Ethiopia, Nigeria and the 
Philippines, have sought to deliver very high numbers of 
services in one event, relying on campaign-style delivery 
mechanisms.
number of interventions and VAs coverage
In 75% of events (n=429), vitamin A coverage ranged 
between 80% and 100%; and for 56% of events (n=322), 
vitamin A coverage was equal to or above 90% (appendix 
3). Regression results in the base model (table 3, model 
1) suggest a slightly negative association between VAS 
coverage and the number of co-delivered interven-
tions (beta=−0·76), which is not statistically significant 
(p=0.185). Alternative regression specifications (table 3, 
models 2–8) confirm this result.
However, the within-between model with additional 
predictors (model 9) suggests that one additional inter-
vention in between-country variation (variable Average 
# interventions (country)) is associated with a statistically 
significant 3.38% decrease in vitamin A coverage. With-
in-country variation of the number of interventions, for 
example, varying number of interventions from one year 
to another, has no effect (variable Difference from average # 
interventions (country)). Results of the sensitivity analyses 
that restrict the sample only to observations with VAS 
coverage over 40%, 60% and 80% show that the associ-
ation between vitamin A coverage and number of inter-
ventions is no longer significant when the low coverage 
outliers are excluded (appendix 1).
number of interventions and association with measles 
coverage
There has also been a steady and high coverage of measles 
vaccines when co-delivered in ICHEs during 2005–2010. 
Out of 142 events that co-delivered the measles vaccine, 
55% had measles coverage data reported in the ICHE 
database. Coverage data for measles derived from 
measles SIAs showed that the majority (79%) of coverage 
outcomes were greater than 90%. The overall median 
(mean) coverage for measles was 96% (91%). Regres-
sion results in the base model indicate a negative asso-
ciation, which is borderline statistically significant at 5% 
levels (p=0·057): on average, for every additional co-in-
tervention, measles vaccine coverage decreases by 1·81% 
(table 4, model 1). The effect is significant at 5% levels 
in the fixed effects specifications (models 4 and 5) and at 
10% levels in the within-between model (p=0·070); in the 
latter, one additional intervention in between-country 
variation is associated with an average decrease of 3·89% 
in measles coverage. However, there is no association 
between coverage and the within-country variation of 
number of interventions. The statistical significance of 
any link between coverage and number of interventions 
disappears when excluding observations with measles 
coverage below 40%, 60% and 80% in the sensitivity anal-
yses (appendix 1).
The distribution of measles vaccine coverage by number 
of interventions (appendix 4) shows that eight or nine 
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interventions appear to show a slight decrease in coverage. 
However, explaining the lower coverage in these events 
requires more detailed studies in particular countries, 
taking into account the make-up of their health systems 
and the broader context.
Packages of interventions and association with VAs coverage
The relationship of the various packages of co-delivered 
interventions and VAS coverage was also examined. The 
top 10 most common package combinations delivered 
during ICHEs between 2005 and 2010 and the median 
coverage of VAS was calculated per package type (box 7). A 
non-parametric Kruskal-Wallis test was used to compare the 
median coverages of VAS across the different packages of 
interventions. The test showed no association at 5% signif-
icance level in VAS coverage across the different packages 
of interventions (p=0·07) (box 8). The specific packages 
of interventions were not associated with VAS coverage. 
The package of VAS—other antigens—growth monitoring 
(‘vag’) appears to result in low VAS coverages (between 6% 
and 49%), which pulled down the median of that package 
group. This lower coverage can only be explained by exam-
ining each country context as to why the coverage was 
lower in those particular events.
dIsCussIon
summary of findings
The findings of our base model do not support the 
hypothesis of an association between the number of 
interventions delivered during ICHEs and coverage 
for VAS or measles vaccination as a result of ICHEs. 
The results generally hold across a range of alternative 
regression specifications, several of which also control for 
health expenditure per capita, health workforce density 
and size of the population under 5 years. However, there 
are also several specifications those suggest the presence 
of a statistically significant association. In these cases, the 
effect is not robust to sensitivity analyses, which exclude 
outliers with extremely low coverage. Overall, we find 
insufficient support for an association between the inter-
vention coverage and number of ICHE interventions.
Interpretation of findings
The study showed that ICHEs represent a frequently used 
platform with the capacity to incorporate a high number 
of interventions without compromising the effectiveness 
of ICHEs or hamper the ability to sustain or increase 
campaign coverage of some interventions, such as VAS 
or measles vaccination. They remain particularly impor-
tant in countries with poor child health outcomes and 
overstretched primary healthcare systems. This relation-
ship was indicated across the different intervention pack-
ages. The study also demonstrated the breadth of ICHEs, 
which exemplified the significant reliance on campaign-
mode of essential health and nutrition services delivery in 
LMICs. While not intuitive, these findings are consistent 
with other studies that demonstrate that SIAs and CHDs 
contribute to improved coverage of interventions.22 This 
study advanced the literature by providing a compre-
hensive overview of integrated campaigns by looking at 
both the CHD and measles immunisation campaigns 
compared with Palmer who looked at CHDs20; by statis-
tically analysing whether the number of interventions 
has any association on the coverage outcomes of key 
interventions and further developing the findings of the 
systematic review of integration of immunisation services 
with other interventions by Wallace et al.2 16 The study 
also extends the analysis of Oliphant et al that explored 
the effects of CHDs on the coverage of child survival 
interventions9 but not the effect of the number of inter-
ventions delivered through integrated campaigns.
However, these findings should be interpreted with 
caution, and it cannot be assumed that further expanding 
the intervention packages of ICHEs will continue to 
achieve positive outcomes.
There are also negative effects of ICHEs those should 
be taken into account. It has been shown that ICHEs 
could undermine the routine provision of basic child 
health services within the national health system,23 as 
seen in Cameroon, Uganda, and Tajikistan, where the 
health staff were less motivated to perform routine activ-
ities and other primary care tasks due to immunisation 
campaigns because of the lack of incentives for routine 
activities.22 24
limitations
We could not control for operational characteristics 
of ICHEs due to the lack of available data, for example, 
number of staff, size of geographical areas covered, costs 
of planning and implementation. The explanatory power 
of the regression models was low, and most country-level 
variables were not statistically significant predictors of inter-
vention coverage. As such, there is substantial potential for 
future analyses to attempt to cover this gap by collecting 
and analysing ICHE operational data in order to better 
understand the determinants of their effectiveness.
As the coverage records were matched by the month that 
campaigns occurred, this may possibly have led to incor-
rect linkages of some interventions, or certain delivered 
interventions may have not been properly recorded. The 
routine data (and to a lesser extent the survey data) are 
likely to have non-negligible non-sampling error as well. 
Some variation in coverage data may be due to reporting 
or data collection and aggregation errors. For example, 
VAS coverage appears to be lower when six and nine inter-
ventions were delivered compared with ICHEs delivering 
different numbers of interventions (box 9). There is no 
apparent reason to expect a systematically lower coverage 
only in ICHEs with six or nine interventions, as this may 
well be an artefact. There are countries that showed VAS 
coverages in the low 20s and 30s during several events while 
delivering six interventions, which may have decreased the 
median VAS coverages for events that delivered six inter-
ventions. Yet, the same countries reached over 90% when 
delivering less or more than six interventions.
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The aggregate analysis does not provide information on 
the conducive factors and implementation practices that 
are required to support countries in carrying out their 
own campaigns. The focus solely on coverage outcomes of 
VAS and measles—for which data was available in the CHD 
database—may not reflect the ability to successfully deliver 
multiple interventions within ICHEs that may include 
other interventions. Appropriate consideration of contex-
tual factors is essential as they may confound the associa-
tion between delivery of the intervention and coverage 
outcomes during the campaigns.
The study suggests, however, that adding interventions 
to established ICHEs may be a viable strategy in LMICs to 
deliver multiple essential health services and can potentially 
be delivered without a decrease in campaign coverage for 
VAS and measles. In addition, there may be positive spill-
over effects, with ICHEs often being a pragmatic vehicle to 
deliver an extensive variety of essential child health services 
beyond immunisation and VAS on a wide scale. Further 
research on the impact of different service configurations 
within multicomponent campaigns is critical, as well as 
obtaining and combining data sets that can support such 
research.
ConClusIon
ICHEs were found to be a popular strategy to deliver essen-
tial child health interventions on a wide-scale across LMICs 
in many regions. ICHEs appear to represent a frequently 
used platform with the capacity to incorporate multiple 
interventions without compromising coverage of key inter-
ventions. More research is needed to better understand 
the contextual and operational factors that determine 
ICHEs’ effectiveness in delivering multiple interventions. 
Furthermore, the role of ICHEs in the context of efforts to 
strengthen health systems in LMICs needs to be re-thought.
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